NEW YORK, Feb. 4, 2025 -- Report with market evolution powered by AI - The global neuroscience antibodies and assays market size is estimated to grow by USD 2.20 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 9.64% during the forecast period. Increasing incidences of neurological disorders is driving market growth, with a trend towards increasing clinical trials. However, high development cost of neuroscience antibodies poses a challenge. Key market players include Abcam plc, Abnova Corp., Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher Scientific Inc..
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF
Neuroscience Antibodies And Assays Market Scope | |
Report Coverage | Details |
Base year | 2023 |
Historic period | 2018 - 2022 |
Forecast period | 2024-2028 |
Growth momentum & CAGR | Accelerate at a CAGR of 9.64% |
Market growth 2024-2028 | USD 2.20 billion |
Market structure | Fragmented |
YoY growth 2022-2023 (%) | 9.13 |
Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution | North America at 46% |
Key countries | US, Germany, UK, France, and China |
Key companies profiled | Abcam plc, Abnova Corp., Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher Scientific Inc. |
Market Driver
Neuroscience antibodies and assays are essential tools in molecular neuroscience research, enabling the characterization of target proteins at the molecular level. Biotechnology companies are at the forefront of developing innovative antibodies and assays kits for neuroscience research, catering to both academic and pharmaceutical industries. These tools play a crucial role in neurological applications, from localization and isolation of proteins to detection methods for neurological markers. Technological advancements in immunochemistry and proteomics have led to collaborative efforts between private organizations and pharmaceutical companies to identify therapeutic targets for neurological conditions such as multiple sclerosis, mental health issues, and neurodegenerative diseases. Neuroscience antibodies and assays are integral to early diagnosis, treatment strategies, and healthcare outcomes in neurological research. Molecular diagnostics, including Western blotting, immunoassays, and clinical chemistry instruments, are key consumers of these advanced tools in hospitals and diagnostic centers.
The global clinical trials landscape has experienced significant expansion over the last two decades due to various factors, including the organization of trials, participation of volunteers, availability of skilled local investigators, enhanced infrastructure, and cost-effective trials in developing countries. In neuroscience, the application of antibodies and assays for disease-specific biomarkers offers several clinical advantages. These benefits include faster and more accurate disease analysis, potential reduction in clinical trial sample size and duration, and the ability to determine if a medication targets its intended goal or alters the disease progression. Neurological disorders, in particular, stand to benefit from this approach, as biomarkers can provide valuable insights into the efficacy of treatments.
Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!
Market Challenges
- Neuroscience antibodies and assays play a crucial role in biotechnology companies' neuroscience research, aiding in the localization and characterization of target proteins at the molecular level for both molecular neuroscience and neurological applications. Pharmaceutical industries use these innovative antibodies for drug target identification and isolation, collaborating with academic institutions and private organizations for technological advancements in neurological markers. Neuroscience antibodies assays are essential for mental health research, including multiple sclerosis, neurological conditions, and neurological disorders. Early diagnosis and treatment strategies rely on these assays, with instruments such as Western blotting and immunoassays used in hospitals and diagnostic centers. Consumables, reagents, and assay kits are essential for research and development in this field, contributing to healthcare infrastructure and improved healthcare outcomes.
- The neuroscience antibodies and assays market involves the production and sale of research antibodies used in neuroscience research. The cost to develop these antibodies varies greatly, with polyclonal antibodies costing around USD1,000, monoclonal antibodies around USD10,000, and recombinant antibodies up to USD50,000. These costs can be a challenge for vendors, as research antibodies do not always generate significant annual sales. Some monoclonal antibodies may not even reach the break-even point for a single research application. Despite these challenges, vendors continue to invest in the development of neuroscience antibodies to meet the demands of researchers in this field.
Discover how AI is revolutionizing market trends- Get your access now!
Segment Overview
This neuroscience antibodies and assays market report extensively covers market segmentation by
- Type
- Consumables
- Instruments
- Application
- Pharmaceutical And Biopharmaceutical Companies
- Academic And Research Institutes
- Hospital And Diagnostic Centers
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
- Technology
- Immunochemistry/Immunoassays
- Molecular Diagnostics
- Clinical Chemistry
- Others
1.1 Consumables- Neuroscience research relies on a diverse range of antibodies, assay kits, and reagents to investigate neurodegenerative diseases, neural development, transmission, and stem cell differentiation. Neuroscience antibodies, such as monoclonal and polyclonal, are essential for initial target detection and amplification in various assays. ELISA kits, a common neuroscience tool, enable the detection and quantification of proteins, including those implicated in neurodegenerative disorders like Amyloid-beta, Tau, and Alpha-synuclein. Reagents like media, sera, and enzymes are also crucial for performing neuroscience assays. The growing significance of neuroscience research and the discovery of new drug targets drive the demand for these consumables, fueling the global neuroscience antibodies and assays market's growth. Some notable neuroscience antibodies include Merck KGaA's Anti-ENO1 Mouse mAb (8G8), Abcam Plc's Anti-beta Amyloid antibody [MOAB-2], and Thermo Fisher Scientific Inc.'s beta Amyloid Polyclonal Antibody (CT695). ELISA kits, such as Merck's High Sensitivity Human Amyloid Beta 40 ELISA and Thermo Fisher Scientific's Tau (Total) Human ELISA Kit, are widely used in neuroscience research.
Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics
Research Analysis
The Neuroscience Antibodies and Assays market encompasses a range of tools and technologies used in the scientific research, biotechnology applications, and biomedical fields to advance our understanding of the complexities of the nervous system. This market includes applications in cellular neuroscience, genomics research, molecular diagnostics, biopharmaceutical industry, and clinical trials. Neurological research spans from the biochemical level to the cellular level, focusing on neurological conditions, disorders, and diseases such as Parkinson's and Alzheimer's. Neuroscience assays play a crucial role in drug development, neurological genetics, neurological surgery, neurological disease prevention, and neurological care. Biotechnology innovations in this field include therapeutic antibodies, neuroprotection, neurological research funding, neurological rehabilitation, brain imaging, and neurological support groups. Neurological specialists and patient advocacy groups are also integral to the advancements in neurological research and treatment. Neurological awareness and neurological disorders treatment are key areas of focus for this market, driving the need for continued biotechnology trends and breakthroughs.
Market Research Overview
Neuroscience antibodies and assays refer to tools used in molecular neuroscience research for the characterization of target proteins at the molecular level. Biochemical and biotechnology companies specialize in the production and development of these antibodies and assays for neuroscience research. Neuroscience antibodies are essential for localization studies, isolation of neurological markers, and detection of neurological conditions such as multiple sclerosis, mental health issues, and neurodegenerative diseases. Collaborative efforts between academic institutions, private organizations, and pharmaceutical companies are driving technological advancements in neuroscience antibodies and assays, enabling early diagnosis and treatment strategies for neurological illnesses. Neurological applications of these tools contribute significantly to healthcare outcomes and pharmaceutical R&D. Immunoassays, Western blotting, and other assay kits are commonly used for neuroscience research. Consumables, instruments, and clinical chemistry play a crucial role in the development and implementation of these assays. Hospitals and diagnostic centers are significant end-users of neuroscience antibodies and assays, contributing to the growth of the market. Innovative antibodies and assays continue to be developed to address the needs of molecular neuroscience, neurological research, and pharmaceutical industries for drug targets and therapeutic targets. The market for neuroscience antibodies and assays is expected to grow as research in this area expands and new applications are discovered.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Type
- Consumables
- Instruments
- Application
- Pharmaceutical And Biopharmaceutical Companies
- Academic And Research Institutes
- Hospital And Diagnostic Centers
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
- Technology
- Immunochemistry/Immunoassays
- Molecular Diagnostics
- Clinical Chemistry
- Others
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
